Literature DB >> 18375907

Value of cytogenetic analysis in the treatment of dermatofibrosarcoma protuberans.

Delphine Kerob1, Florence Pedeutour, Christophe Leboeuf, Olivier Verola, Eric de Kerviler, Jean Marie Servant, Farid Sarandi, Guilhem Bousquet, Isabelle Madelaine-Chambrin, Christelle Pruvost, Fabien Calvo, Anne Janin, Celeste Lebbe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18375907     DOI： 10.1200/JCO.2007.14.7330

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

1.  A Tete - a - tete of benign, borderline and malignant fibrohistiocytic tumor.

Authors:  Rashmi M V; Pavithra P; Shivakumarappa G M
Journal:  Iran J Pathol       Date:  2016

2.  Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.

Authors:  Piotr Rutkowski; Martine Van Glabbeke; Cathryn J Rankin; Wlodzimierz Ruka; Brian P Rubin; Maria Debiec-Rychter; Alexander Lazar; Hans Gelderblom; Raf Sciot; Dolores Lopez-Terrada; Peter Hohenberger; Allan T van Oosterom; Scott M Schuetze
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

Review 3.  Gene translocations in musculoskeletal neoplasms.

Authors:  Balaji Krishnan; Gaurav Khanna; Denis Clohisy
Journal:  Clin Orthop Relat Res       Date:  2008-06-20       Impact factor: 4.176

4.  Fluorescence in situ hybridization analysis is a helpful test for the diagnosis of dermatofibrosarcoma protuberans.

Authors:  Marie Karanian; Gaëlle Pérot; Jean-Michel Coindre; Frédéric Chibon; Florence Pedeutour; Agnès Neuville
Journal:  Mod Pathol       Date:  2014-08-01       Impact factor: 7.842

5.  Advances in molecular characterization and targeted therapy in dermatofibrosarcoma protuberans.

Authors:  Piotr Rutkowski; Agnieszka Wozniak; Tomasz Switaj
Journal:  Sarcoma       Date:  2011-03-30

6.  Neoadjuvant treatment of Dermatofibrosarcoma Protuberans of pancreas with Imatinib: case report and systematic review of literature.

Authors:  Mashaal Dhir; David G Crockett; Todd M Stevens; Peter T Silberstein; William J Hunter; Jason M Foster
Journal:  Clin Sarcoma Res       Date:  2014-08-06

Review 7.  Dermatofibrosarcoma protuberans: from translocation to targeted therapy.

Authors:  Jonathan Noujaim; Khin Thway; Cyril Fisher; Robin L Jones
Journal:  Cancer Biol Med       Date:  2015-12       Impact factor: 4.248

8.  Long-Term Outcome of Neoadjuvant Tyrosine Kinase Inhibitors Followed by Complete Surgery in Locally Advanced Dermatofibrosarcoma Protuberans.

Authors:  Jessica Beaziz; Maxime Battistella; Julie Delyon; Cécile Farges; Oren Marco; Cécile Pages; Christine Le Maignan; Laetitia Da Meda; Nicole Basset-Seguin; Matthieu Resche-Rigon; Anouk Walter Petrich; Delphine Kérob; Céleste Lebbé; Barouyr Baroudjian
Journal:  Cancers (Basel)       Date:  2021-05-06       Impact factor: 6.639
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.